Aspyra, Inc. (AMEX: APY), a leading provider of clinical and diagnostic information solutions for the healthcare industry, today announced Ade Lawal has joined the Company as Vice President of Strategy and Business Development. Mr. Lawal brings with him over a decade of experience in consulting and operations management, most recently as Director of Service for GE Healthcare. Having attained the Lean Six Sigma Black Belt certification from GE Healthcare, Mr. Lawal has successfully implemented various operational and service-oriented improvement efficiencies for the healthcare business environment. His efforts resulted in number one customer satisfaction rating within GE based on Net Promoter Score for southern California, and service revenue growth of three times the industry average. Prior to GE, Mr. Lawal worked as Senior Consultant for KPMG Consulting. He holds an MBA from Harvard Business School, Bachelor of Science from University of Virginia and is also a Certified Public Accountant. Ade Lawal commented, �In addition focusing on customer satisfaction and internal process improvements, I plan on contributing to the top line growth by working with sales and marketing to build business relationships with strategic partners that further promote Aspyra as a leader in the healthcare industry.� He continued, �I am excited to be part of Aspyra as we take the Company forward.� Aspyra CEO, Jim Zierick stated, �With Ade�s experience in service operations and customer satisfaction, his responsibilities at Aspyra will include working with various members of management to implement quality service initiatives and metrics that improve our business efficiencies and costs. These initiatives are part of the building blocks that will help scale the business for profitable growth.� Aspyra solutions provide integrated technologies and services that improve the efficiency, safety and quality of patient care. Aspyra works directly with customers through its own sales and service staff as well as through an extensive partner network. The Company currently counts over 440 customers and over 650 application installations in its installed base. About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company�s management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company�s long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025 Aspyra 차트를 더 보려면 여기를 클릭.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025 Aspyra 차트를 더 보려면 여기를 클릭.